MK-6892
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 525688

CAS#: 917910-45-3

Description: MK-6892 is a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals. MK-6892 displays excellent receptor activity, good PK across species, remarkably clean off-target profiles, good ancillary pharmacology, and superior therapeutic window over niacin.


Chemical Structure

img
MK-6892
CAS# 917910-45-3

Theoretical Analysis

MedKoo Cat#: 525688
Name: MK-6892
CAS#: 917910-45-3
Chemical Formula: C19H22N4O5
Exact Mass: 386.16
Molecular Weight: 386.408
Elemental Analysis: C, 59.06; H, 5.74; N, 14.50; O, 20.70

Price and Availability

Size Price Availability Quantity
100mg USD 1650 2 Weeks
200mg USD 2650 2 Weeks
500mg USD 3650 2 Weeks
1g USD 4450 2 Weeks
2g USD 7950 2 Weeks
Bulk inquiry

Synonym: MK6892; MK 6892; MK-6892

IUPAC/Chemical Name: 2-(3-(3-(5-hydroxypyridin-2-yl)-1,2,4-oxadiazol-5-yl)-2,2-dimethylpropanamido)cyclohex-1-ene-1-carboxylic acid

InChi Key: CJHXBFSJXDUJHP-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H22N4O5/c1-19(2,18(27)21-13-6-4-3-5-12(13)17(25)26)9-15-22-16(23-28-15)14-8-7-11(24)10-20-14/h7-8,10,24H,3-6,9H2,1-2H3,(H,21,27)(H,25,26)

SMILES Code: O=C(C1=C(NC(C(C)(C)CC2=NC(C3=NC=C(O)C=C3)=NO2)=O)CCCC1)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: MK-6892 is a potent, selective, and full agonist for the high affinity nicotinic acid (NA) receptor GPR109A.
In vitro activity: TBD
In vivo activity: TBD

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 50.0 135.72

Preparing Stock Solutions

The following data is based on the product molecular weight 386.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: TBD
In vitro protocol: TBD
In vivo protocol: TBD

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Kim HY, Jadhav VB, Jeong DY, Park WK, Song JH, Lee S, Cho H. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor. Arch Pharm Res. 2015 Jun;38(6):1019-32. doi: 10.1007/s12272-015-0560-4. Epub 2015 Jan 20. PubMed PMID: 25599616.
2: Shen HC, Ding FX, Raghavan S, Deng Q, Luell S, Forrest MJ, Carballo-Jane E, Wilsie LC, Krsmanovic ML, Taggart AK, Wu KK, Wu TJ, Cheng K, Ren N, Cai TQ, Chen Q, Wang J, Wolff MS, Tong X, Holt TG, Waters MG, Hammond ML, Tata JR, Colletti SL. Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate. J Med Chem. 2010 Mar 25;53(6):2666-70. doi: 10.1021/jm100022r. PubMed PMID: 20184326.